Characterisation of cultivation of the human cell line AGE1.HN.AAT
© Schräder et al; licensee BioMed Central Ltd. 2011
Published: 22 November 2011
Human cell lines are an interesting alternative to CHO cells for the production of recombinant proteins and monoclonal antibodies, because of their ability to produce genuine human posttranslational modifications. The human cell line AGE1.HN.AAT (ProBioGen, Berlin, Germany), that originated from human neural precursor tissue, has been adapted to serum-free conditions and cultivated in many different systems. Here we present our results using this cell line in a scale-up of batch cultivation from 50 mL vented polypropylene tube on a shaking platform, polycarbonate shakeflask (cultivation volume from 50 mL up to 300 mL), a 2 L-glass vessel stirred tank reactor and a 20 L-stainless steel stirred tank reactor (both Sartorius Stedim, Goettingen, Germany).
Materials and methods
Cultivations were performed with chemically-defined and animal-component-free media 42-MAX-UB (Teutocell, Bielefeld, Germany). Batch-cultivations were performed in 50 mL-bioreactor tubes (TPP, Switzerland) shakeflasks (Corning Life Sciences, Netherlands), 2 L-glass vessel and 20 L-stainless steel vessel (both Sartorius-Stedim, Germany). Chemostat-cultivation was done in 0.5 L-bioreactor (DASGIP, Juelich, Germany) with a media exchange rate of 7 mL/h. As a further cultivation system a dialysis-reactor (Bioengineering, Wald, Switzerland) was established, with a 1.3 L cell-containing inner chamber and a 4 L media reservoir in the outer chamber, separated by a semipermeable dialysis membrane.
Proliferation in controlled and uncontrolled systems
Cultivation in 2 L-glass vessel is as well feasible for batch process as well as preculture for 20 L-vessel. Cultivation at a 20 L-scale resulted in delayed cell growth but did not affect the final cell concentration (refer to figure 1b). AGE1.HN.AAT cells show a strong growth-coupled productivity as shown in figure 1c.
No difference between 2 L- and 20 L-vessel concerning spec. productivity and spec. growth rate were observed. A scale-up of cultivation-volume in batch process is definitely possible.
Cultivations with other systems
Cultivation of AGE1.HN.AAT cells in dialysis-reactor is also possible and batch cultivation without media-exchange in the outer chamber showed maximum cell density up to 1.6 E7 viable cells per milliliter in the inner chamber after eight days of cultivation.
Chemostat-cultivation in 0.5 L-glass vessel shows constant cell density at 2.5 E6 cells/mL for more than 14 days.
Cultivation of AGE1.HN cell line is possible in different regulated and unregulated systems and at different scales. Cell specific productivity and titer of the AGE1.HN.AAT producer cell line depend mainly on cell growth. The cells are easily scalable from 2 to 20 L batch cultivation in STR. Other cultivation strategies have been established successfully (incl. chemostat and dialysis-bioreactor) documenting the potential of the AGE1.HN cell line.
The work presented was part of SysLogics (Systems biology of cell culture for biologics), which is funded by German Federal Ministry of Education and Research. Cultivation of 125 mL shakeflasks and bioreactor tubes were done in Saarbruecken, dialysis cultivation in Hamburg, chemostat-process was done in Magdeburg, while 250 mL shakeflask, 2 L-glass vessel and 20 L-stainless steel bioreactor-cultivation were performed in Bielefeld.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.